Skip to content

The clinical research of the new type of cervical and lumbar traction device for the cervical and lumbar pain

The research and development of new type of cervical and lumbar traction device

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011349
Enrollment
Unknown
Registered
2017-05-11
Start date
2017-05-11
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical and lumbar pain

Interventions

Treatment group:The new type of cervical lumbar traction device treatment
Control group:Traditional cervical and lumbar traction devices treatment

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) meet the diagnostic criteria for cervical spondylosis and low back pain; (2) aged 40 to 70 years old, male or female; (3) volunteer as the subject, and can accept the test drug, to ensure the completion of treatment.

Exclusion criteria

Exclusion criteria: (1) does not meet the above diagnostic criteria; (2) under the age of 40, over 70 years of age; (3) combined with cardiovascular, liver, kidney and hematopoietic system and other serious primary disease; (4) allergy; (5) patients with mental illness or senile dementia; (6) do not cooperate with the treatment; (7) who is participating in other clinical trials or three months participated in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale, VAS;

Secondary

MeasureTime frame
Neck Disability Index, NDI;Oswestry Disability Index, ODI;

Countries

China

Contacts

Public ContactChen Bo

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

cbm818@126.com+86 18516526835

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026